Selepressin, formerly known as FE-202158, is a potent, selective vasopressin V1a receptor agonist potentially for the treatment of septic shock. is a potent, Selepressin is an analogue of vasopressin which is under development by Ferring Pharmaceuticals for the treatment of vasodilatory hypotension in septic shock. References: Stolk RF, van der Poll T, Angus DC, van der Hoeven JG, Pickkers P, Kox M. Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis. Am J Respir Crit Care Med. 2016 Sep 1;194(5):550-8. doi: 10.1164/rccm.201604-0862CP. PubMed PMID: 27398737.

纯度：≥98%

CAS：876296-47-8